Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any person referred to the Hahnemann University Hospital Electrophysiology Laboratory for a clinically indicated ICD implant~Exclusion Criteria:~* Any person under the age of 18 years~* Inability to give an informed consent~* Allergy to lidocaine~* Receiving lidocaine treatment for pain or arrhythmia~* Contraindication for DFT testing~* Not consenting for DFT testing~* Receiving energy other than 10-12.5 joules as initial DFT test~* Implant of ICD on the right side~* DFT not planned to be performed during ICD implant~* Epicardial placement of ICD leads~* Use of single coil ICD lead~* Subpectoral ICD implantation~* Cephalic cutdown used for central venous access~* Require more than 3mg/kg of 1% SQ lidocaine for local anesthesia~* Pregnant women or prisoners

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): treatment arm
- Saline (Type: PLACEBO_COMPARATOR): placebo arm

Based on this trial design, predict the completion outcome and termination type (if applicable).